greeksoup/ stock research
Stock research / United States / UHS · Services-General Medical & Surgical Hospitals, Nec · NYSE

Universal Health Services Inc. (UHS)

Universal Health Services owns and operates, through subsidiaries, acute care hospitals, outpatient facilities and behavioral health care facilities. As of 25 February 2026 it owned or operated 375 inpatient facilities and 168 outpatient and other facilities in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It is a Delaware corporation organised in 1979 and based in King of Prussia, Pennsylvania.

Universal Health Services Inc.

Universal Health Services owns and operates, through subsidiaries, acute care hospitals, outpatient facilities and behavioral health care facilities. As of 25 February 2026 it owned or operated 375 inpatient facilities and 168 outpatient and other facilities in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It is a Delaware corporation organised in 1979 and based in King of Prussia, Pennsylvania.

The two divisions

The acute care side in the United States is 29 inpatient acute care hospitals, 35 free-standing emergency departments, 13 outpatient centres and one surgical hospital. The behavioral health side is much larger by facility count: 182 inpatient and 110 outpatient facilities in the United States, and 161 inpatient and seven outpatient facilities in the United Kingdom. The company changed the way it counts outpatient behavioral health facilities in the third quarter of 2025, and says substantially all of the increase from prior periods comes from that change. Acute care hospitals, outpatient facilities and the company's commercial health insurer were approximately 57% of consolidated net revenues in each of 2025 and 2024, and behavioral health care facilities with the insurer approximately 43%.

What the hospitals do

Services include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, paediatric services, pharmacy services and behavioral health services. The parent supplies capital and a set of management services to the facilities: central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing and public relations. Each hospital is run day to day by a chief executive employed by a subsidiary, with a Board of Governors including members of the hospital's medical staff overseeing medical, professional and ethical practice.

The United Kingdom

Behavioral health facilities in the United Kingdom are a substantial part of the group. They brought in approximately $1.001 billion in 2025 against $880 million in 2024, and held total assets of approximately $1.531 billion at 31 December 2025 against $1.358 billion a year earlier.

Strategy and the market

The company states that it believes community-based hospitals will remain the focal point of the healthcare delivery network, and it follows a philosophy of self-determination for itself and its hospitals. It selectively acquires, builds or leases additional hospitals and also considers divesting facilities. Pressure to contain costs, and technology that allows more procedures to be done without an overnight stay, have pushed payers toward ambulatory and outpatient care, and the company is responding by expanding outpatient services and by working on staffing levels, equipment use, patient management and billing and collection. Acute care volumes are typically seasonal, with higher patient volumes in the first and fourth quarters.

Who pays

Payments come from private insurers including managed care plans, the federal government under Medicare, state governments under their Medicaid programmes and directly from patients. The industry is subject to government healthcare participation requirements, licensure and accreditation rules, reimbursement rules, health information privacy and security rules, and Medicare and Medicaid fraud and abuse provisions, including prohibitions on kickbacks, false claims and physician self-referral, with exclusion from government programmes, fines and repayment among the possible consequences of a violation.

People

There were approximately 101,500 employees at 31 December 2025: approximately 88,100 in the United States, of whom approximately 65,000 were full-time, and approximately 13,400 in the United Kingdom. Hospitals are staffed by licensed physicians admitted to the medical staff of the individual hospital, many of whom also hold privileges elsewhere. Approximately 460 physicians are employed within the acute care division and approximately 445 within the behavioral health division, directly or through contracts with affiliated group practices. Approximately 1,070 employees at three hospitals are unionised.

From Universal Health Services' annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in Universal Health Services became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 6 November 2026
Revenue
$4.7 billion
+5.3% on the year · +2.1% on the quarter
Q4 FY2024Q3 FY2026
Net income
$309 million
-17.2% on the year · -13.9% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$5.22
-10.9% on the year · -12.7% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Last full yearFY2025ended 31 December 2025 · 10-K filed 25 February 2026
Revenue
$17.4 billion
+9.7% on the year
FY2018FY2025
Net income
$1.5 billion
+30.4% on the year
FY2018FY2025
Diluted EPS
$23.10
+37.3% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsUniversal Health Services (UHS) reported revenue of $17.4 billion for fiscal 2025, the year ended 31 December 2025, up 9.7% on the year before. Net income was $1.5 billion and diluted earnings per share $23.10. Revenue was $15.8 billion in fiscal 2024, $14.3 billion in fiscal 2023, $13.4 billion in fiscal 2022 and $12.6 billion in fiscal 2021. Net income in the same years was $1.1 billion, $718 million, $676 million and $992 million. Over the twelve months to 30 September 2026, Universal Health Services reported revenue of $18.4 billion and net income of $1.5 billion. Revenue grew 8.5% a year, compounded, over the five years to fiscal 2025. Universal Health Services declared $0.80 a share in dividends over the last four quarters and had 58 million shares outstanding at the latest filed count. At 30 September 2026 it carried $5.7 billion of debt and $169 million of cash. At the close of 6 November 2026 the market cap of Universal Health Services was $11.3 billion, 8.2 times its earnings over the last twelve months.

Ratios

From the filings

ROE19.2%
ROCE15.0%
Operating margin10.8%
Net margin8.0%
FCF margin6.1%
Interest cover11.3x
Debt to equity0.75x
Cash conversion1.41x
Share count, last 12 months-7.7%
Sales CAGR, 3 years9.0%
Profit CAGR, 3 years30.1%
EPS, TTM$23.91

At the close of 6 November 2026

Price$195.53
Market cap$11.3 billion
Stock P/E8.2x
Price to book1.5x
EV / EBITDA6.3x
Dividend yield0.4%
Market cap / sales0.61x
52-week high$244.18
52-week low$141.17
Price, 1 year-13.6%
Price CAGR, 3 years14.5%
Price CAGR, 5 years8.5%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on long-term debt as Universal Health Services Inc. files it, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.
UHSgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue3,2753,2933,3233,3363,4473,4683,5483,5633,7043,8443,9083,9634,1144,1004,2844,4954,4864,4954,6384,733
Operating income314233233276261279280285331389436384472455500522517503517454
Operating margin10%7%7%8%8%8%8%8%9%10%11%10%11%11%12%12%12%11%11%10%
Interest expense19.221.725.735.743.950.948.853.453.652.848.944.739.740.135.438.442.237.139.956.3
Pre-tax income307200210234222214225221281336382342438420473497581469479414
Tax rate24%24%24%25%23%24%25%24%22%21%23%22%23%23%23%24%23%24%24%24%
Net income239154164183175163171167216262289259332317353373446349358309
Net margin7%5%5%5%5%5%5%5%6%7%7%7%8%8%8%8%10%8%8%7%
Diluted EPS$3.00$2.02$2.20$2.50$2.43$2.28$2.42$2.40$3.16$3.82$4.26$3.80$4.96$4.80$5.43$5.86$7.06$5.65$5.98$5.22
Operating cash flow32244532.6221297291363162452396679333658360549381575402443637
Capital expenditure190200208162164169168200206209241248246239266229281217228215
Free cash flow132245-17559.1133122195-38.324618843885.0412121283152293184216422
Buybacks45036620015811085.012517616214295.9183250223155237352164321245
Dividends paid15.614.914.814.614.314.214.013.713.513.613.413.313.013.512.912.512.413.011.811.8
Shares outstandingn/an/an/an/an/an/an/an/an/an/an/an/a65m64m64m62m61m61m59m58m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2010 †FY2011 †FY2012 †FY2013 †FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020 †FY2021FY2022FY2023FY2024FY2025TTM
Revenue4,9006,7606,9617,3688,2059,0439,76610,41010,77211,37811,55912,64213,39914,28215,82817,36518,353
Operating income5068979431,0151,0631,2591,2811,2801,1751,2161,3581,3631,0041,1751,6821,9941,991
Operating margin10.3%13.3%13.5%13.8%13.0%13.9%13.1%12.3%10.9%10.7%11.8%10.8%7.5%8.2%10.6%11.5%10.8%
Interest expense77.620117914613411312514515516310683.7127207186156176
Pre-tax income4286967648699301,1461,1561,1351,0351,0661,2521,2938669401,4981,9721,944
Income tax152247275315325395409364237239299306209221335461459
Effective tax rate35.6%35.5%36.0%36.3%34.9%34.5%35.4%32.0%22.9%22.4%23.9%23.6%24.2%23.5%22.4%23.4%23.6%
Net income2303984435115456817027527808159449926767181,1421,4891,462
Net margin4.7%5.9%6.4%6.9%6.6%7.5%7.2%7.2%7.2%7.2%8.2%7.8%5.0%5.0%7.2%8.6%8.0%
Diluted EPS$2.34$4.04$4.53$5.14$5.42$6.76$7.14$7.81$8.31$9.13$10.99$11.82$9.14$10.23$16.82$23.10$23.91
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2010 to FY2025

FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
Acute Care Hospital Services3,2723,4243,4613,6034,1784,6335,1135,4855,7206,1656,3377,1087,6478,0818,9449,92657.2%
Behavioral Health Services1,5973,3093,4603,7264,0124,4004,6454,9075,0395,2105,2095,5045,7306,1916,8737,42642.8%
Other30.627.439.839.514.810.68.318.513.53.612.930.222.99.710.613.40.1%
Acute Care Hospital ServicesBehavioral Health ServicesOther
6.8FY20117.4FY20139.0FY201510.4FY201711.4FY201912.6FY202114.3FY202317.4FY2025

$ billion; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Profit by segment FY2010 to FY2023

The profit before tax each segment reports. Costs Universal Health Services does not charge to a segment are left out, so the segments can add up to more than the company's own profit before tax.

FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023Margin
FY2023
Acute Care Hospital Services2242221751582873223874595094834705011782743.4%
Behavioral Health Services31066675480684590587681075473485285380089714.5%
Other-105-192-166-94.8-202-80.7-106-134-229-151-69.8-61.1-112-231n/a
Acute Care Hospital ServicesBehavioral Health ServicesOther
696FY2011869FY20131,146FY20151,135FY20171,066FY20191,293FY2021940FY2023

$ million; the figure over a bar is all the segments together; a year a segment lost money, it hangs below the line. Hover a block for its profit, sales and margin.

FY2023Share of salesShare of profit
Acute Care Hospital Services57%23%
Behavioral Health Services43%77%
Otherunder 1%a loss

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has a profit before tax figure. A margin is a segment's profit before tax over its own sales.

Revenue by product or service FY2016 to FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
Managed Care (HMO and PPOs)3,2533,3623,4903,6353,4273,9574,0134,2114,4964,90228.2%
Medicaid1,1801,2061,1841,2081,2031,2921,5121,5332,2522,68715.5%
Managed Medicaid1,2371,3891,5301,6791,7151,9472,2072,2912,3042,48314.3%
Managed Medicare6807919291,0481,1051,3631,5611,7141,8842,08012.0%
Medicare1,7291,8171,8761,8891,6911,6541,6161,6071,6691,85610.7%
Other Patient Revenue and Adjustments, Net7417186516977458437469811,1131,2407.1%
Other Non-patient Revenue7047006086701,0898981,0611,1831,2301,1156.4%
UK Revenue2414275055545846886857618801,0015.8%
Managed Care (HMO and PPOs)MedicaidManaged MedicaidManaged MedicareMedicareOther Patient Revenue and Adjustments, NetOther Non-patient RevenueUK Revenue
10.4FY201711.4FY201912.6FY202114.3FY202317.4FY2025

$ billion; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

First forecast against the result

Universal Health Services's EPS landed at or above the top of the range in 2 and under it in 2 of the 4 years shown (FY2012 to FY2016).

−9.8%FY2012+0.7%FY2013+0.8%FY2014−10.8%FY2016
  • At or above the top of the range
  • Inside the range
  • Under the range

Each bar is the year's result against the top of its first forecast range, in per cent of the top. Hover a bar for the figures.

Fiscal yearFirst forecast
EPS
Result
FY2012$4.33 to $4.48$4.04
FY2013$4.35 to $4.50$4.53
FY2014$4.80 to $5.10$5.14
FY2016$7.12 to $7.58$6.76
First forecast
The full-year range the company gave with its fourth-quarter results for the year before, before any later change to it.
Result
The figure the company reported for that year with its next fourth-quarter results.
Years left out
Where the forecast or the result could not be read with confidence. Each figure in the table links to the results release it comes from.

Cash flow

FY2010 †FY2011 †FY2012 †FY2013 †FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020 †FY2021FY2022FY2023FY2024FY2025TTM
Operating cash flow5017117998841,0361,0681,3341,2481,2751,4382,3608849961,2682,0671,8642,056
Capital expenditure2392863633583913795205586656347318567347439441,015941
Free cash flow2624254365266456898146906108041,62928.02625251,1238491,115
Free cash flow margin5.3%6.3%6.3%7.1%7.9%7.6%8.3%6.6%5.7%7.1%14.1%0.2%2.0%3.7%7.1%4.9%6.1%
Cash from investing-2,194-286-790-383-833-913-1,155-685-747-688-803-914-647-763-911-1,071-1,868
Cash from financing1,713-413-27.4-507-187-125-171-519-492-845-385-1,069-318-494-1,145-750-102
Depreciation and amortisation224296309337376399417448453490510533582568585619661
Share-based compensation16.818.222.527.831.140.048.156.766.669.465.873.785.487.799.395.796.9
Buybacks11.560.519.227.21012103533643977712071,2218335476719681,082
Dividends paid19.419.558.419.629.739.538.938.237.353.017.365.958.455.553.351.348.9
Dividend per share$0.20$0.20$0.60$0.20$0.30n/an/an/a$0.40$0.60n/a$0.80$0.80$0.80$0.80$0.80n/a
Diluted shares, weighted98m99m98m99m101m101m98m96m94m89m86m84m74m70m68m64m59m
Shares outstanding at period endn/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a58m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2010 †FY2011 †FY2012 †FY2013 †FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020 †FY2021FY2022FY2023FY2024FY2025TTM
Funded by
Shareholders' equity1,9792,2962,7133,2503,7364,2504,5334,9905,3895,5046,3176,0905,9216,1496,6667,2767,597
Non-controlling interest45.050.852.650.255.159.564.461.976.574.884.810344.847.783.363.071.0
Redeemable equity2122182342182402439.36.74.34.34.65.14.75.213.370.674.2
Debt3,9163,6543,7303,3093,2793,4314,1364,0403,9993,9843,8564,1904,8084,9124,5054,7535,700
Operating lease liabilitiesn/an/an/an/an/an/an/an/a0.0270278305396383376341389
Finance lease liabilitiesn/an/an/an/an/an/an/an/an/a16.450.876.672.569.687.285.4n/a
Other liabilities1,3771,4461,4711,4841,6421,6511,5751,6641,7971,8142,8852,3242,2482,4012,7392,9403,355
Total liabilities and equity7,5287,6658,2018,3128,9519,63410,31810,76211,26511,66813,47713,09413,49413,96814,47015,52817,186
Owned
Fixed assets3,2533,2883,3823,4423,6803,8364,3314,5724,8485,0175,3735,8745,9186,1256,5727,0087,218
Goodwill2,5902,6283,0373,0493,2913,5963,7843,8253,8453,8703,8833,9633,9093,9323,9333,9904,737
Intangible assetsn/an/an/an/a98.021922822017383.782.681.078.177.076.375.9n/a
Cash and equivalents29.541.223.517.232.161.233.774.410561.31,224115103119126138169
Receivables8389701,0671,1171,2831,3021,4401,5011,5101,5611,7291,7472,0182,2382,1782,6022,814
Other assets8187396916865686195015707851,0761,1851,3141,4681,4761,5851,7132,248
Total assets7,5287,6658,2018,3128,9519,63410,31810,76211,26511,66813,47713,09413,49413,96814,47015,52817,186
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded6.7%8.5%9.0%8.0%
Profit growth, compounded8.1%9.5%30.1%6.3%
Return on equity, average15.2%15.4%16.4%20.5%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Universal Health Services' revenue in fiscal 2025?

Universal Health Services (UHS) reported revenue of $17.4 billion for fiscal 2025, the year ended 31 December 2025, up 9.7% on the year before.

How much did Universal Health Services earn in fiscal 2025?

Net income was $1.5 billion for fiscal 2025, and diluted earnings per share $23.10.

What is Universal Health Services' P/E ratio?

At the close of 6 November 2026, Universal Health Services traded at 8.2 times its earnings over the twelve months to 30 September 2026.

What is Universal Health Services' market cap?

The market cap of Universal Health Services was $11.3 billion at the close of 6 November 2026.

Does Universal Health Services pay a dividend?

Yes. Universal Health Services declared $0.80 a share in dividends over the four quarters to 30 September 2026.

Peers: Healthcare

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
HCA Healthcare, Inc. HCA$104.4 billion16.40n/a12.5%5.8%n/a0.6%
Tenet Healthcare Corp. THC$22.6 billion8.2253.3%24.4%6.2%2.43n/a
Encompass Health Corp. EHC$13.5 billion21.4924.0%18.3%9.4%0.970.6%
BrightSpring Health Services, Inc. BTSG$13.4 billion36.3118.8%3.4%22.9%1.00n/a
Davita Inc. DVA$12.1 billion14.09n/a15.0%6.4%n/an/a
Universal Health Services Inc. UHS$11.3 billion8.1819.2%10.8%8.0%0.750.4%
Ensign Group, Inc. ENSG$10.6 billion26.9615.6%9.0%17.5%0.080.1%
Pacs Group, Inc. PACS$7.9 billion28.8122.9%7.4%12.4%0.22n/a
Caris Life Sciences, Inc. CAI$7.2 billion76.4515.0%13.4%n/a0.61n/a
Surgery Partners, Inc. SGRY$3.0 billionn/a-5.3%11.4%4.0%2.25n/a
Ardent Health, Inc. ARDT$2.4 billion16.7910.5%4.5%2.0%0.79n/a
Community Health Systems Inc. CYH$311 million8.48n/a10.9%-7.8%n/an/a
All 59 in Healthcare
CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
HCA Healthcare, Inc. HCA$104.4 billion16.40n/a12.5%5.8%n/a0.6%
Natera, Inc. NTRA$44.9 billionn/a-8.8%-9.0%37.4%0.04n/a
Labcorp Holdings Inc. LH$29.8 billion30.0811.3%10.3%6.0%0.660.8%
Quest Diagnostics Inc. DGX$28.1 billion25.4614.8%14.6%9.1%0.731.3%
Tenet Healthcare Corp. THC$22.6 billion8.2253.3%24.4%6.2%2.43n/a
Guardant Health, Inc. GH$20.4 billionn/an/a-39.4%41.7%n/an/a
Encompass Health Corp. EHC$13.5 billion21.4924.0%18.3%9.4%0.970.6%
BrightSpring Health Services, Inc. BTSG$13.4 billion36.3118.8%3.4%22.9%1.00n/a
Davita Inc. DVA$12.1 billion14.09n/a15.0%6.4%n/an/a
Universal Health Services Inc. UHS$11.3 billion8.1819.2%10.8%8.0%0.750.4%
Ensign Group, Inc. ENSG$10.6 billion26.9615.6%9.0%17.5%0.080.1%
Pacs Group, Inc. PACS$7.9 billion28.8122.9%7.4%12.4%0.22n/a
Caris Life Sciences, Inc. CAI$7.2 billion76.4515.0%13.4%n/a0.61n/a
Chemed Corp. CHE$6.9 billion25.2732.8%13.9%5.2%0.270.5%
Hims & Hers Health, Inc. HIMS$6.1 billionn/a-43.8%-6.0%28.0%4.21n/a
RadNet, Inc. RDNT$6.0 billionn/a-1.9%3.1%18.9%1.22n/a
BillionToOne, Inc. BLLN$5.4 billion104.298.7%10.2%n/a0.16n/a
Grail, Inc. GRAL$5.4 billionn/a-16.6%-347.3%17.5%0.00n/a
Concentra Group Holdings Parent, Inc. CON$5.3 billion24.9642.7%16.9%11.8%3.000.6%
LifeStance Health Group, Inc. LFST$5.2 billion72.474.8%6.2%22.6%0.18n/a
Option Care Health, Inc. OPCH$4.7 billion22.7716.2%5.9%4.0%0.87n/a
Sotera Health Co. SHC$4.6 billion26.6823.7%n/a6.9%2.91n/a
CareDx, Inc. CDNA$4.1 billion32.8627.5%23.4%38.9%0.00n/a
Acadia Healthcare Company, Inc. ACHC$3.4 billionn/a-55.8%-31.7%4.5%1.16n/a
National Healthcare Corp. NHC$3.3 billion28.7610.2%9.8%5.6%0.451.3%
Privia Health Group, Inc. PRVA$3.1 billion93.924.3%2.1%19.2%0.00n/a
Surgery Partners, Inc. SGRY$3.0 billionn/a-5.3%11.4%4.0%2.25n/a
Aveanna Healthcare Holdings, Inc. AVAH$2.9 billion10.7695.6%10.5%19.5%4.52n/a
Progyny, Inc. PGNY$2.6 billion31.9622.0%9.4%5.5%0.00n/a
Pediatrix Medical Group, Inc. MD$2.4 billion17.0017.7%10.9%1.9%0.68n/a
Ardent Health, Inc. ARDT$2.4 billion16.7910.5%4.5%2.0%0.79n/a
Addus HomeCare Corp. ADUS$2.3 billion20.709.4%10.3%11.5%0.02n/a
Brookdale Senior Living Inc. BKD$2.2 billionn/an/a6.8%-8.4%n/an/a
Fortrea Holdings Inc. FTRE$2.1 billionn/a-12.9%0.5%-3.4%1.98n/a
Veracyte, Inc. VCYT$1.9 billion15.568.9%17.1%17.5%0.00n/a
agilon health, Inc. AGL$1.9 billion20.59-31.0%-2.6%2.0%0.11n/a
GeneDx Holdings Corp. WGS$1.9 billionn/a-43.5%-20.3%25.4%0.41n/a
Personalis, Inc. PSNL$1.7 billionn/a-56.1%-156.7%16.9%n/an/a
Healthcare Services Group Inc. HCSG$1.6 billion16.2919.7%n/a4.0%0.00n/a
Teladoc Health, Inc. TDOC$1.6 billionn/a-12.0%-6.6%-2.4%0.77n/a
Sonida Senior Living, Inc. SNDA$1.6 billionn/a-14.8%-11.8%70.0%1.88n/a
U S Physical Therapy Inc. USPH$1.5 billionn/a7.0%9.1%10.4%0.571.8%
Lumexa Imaging Holdings, Inc. LMRI$1.3 billionn/an/an/an/a1.36n/a
Pennant Group, Inc. PNTG$1.3 billion36.738.5%5.8%38.7%0.47n/a
InnovAge Holding Corp. INNV$1.2 billion149.673.5%1.4%15.1%0.19n/a
Castle Biosciences Inc. CSTL$1,000 millionn/a-4.8%-7.4%9.8%0.020.0%
AdaptHealth Corp. AHCO$999 millionn/a-33.2%-11.5%-3.2%1.54n/a
Omada Health, Inc. OMDA$936 million71.905.1%2.1%n/a0.00n/a
Starling Oncology, Inc. STLN$682 millionn/an/a-3.4%34.6%n/an/a
Fulgent Genetics, Inc. FLGT$660 millionn/a-9.2%-39.2%4.7%0.00n/a
SBC Medical Group Holdings Inc. SBC$522 million10.8318.6%37.3%-6.9%0.14n/a
Viemed Healthcare, Inc. VMD$348 million24.0510.4%7.8%21.8%0.03n/a
Community Health Systems Inc. CYH$311 million8.48n/a10.9%-7.8%n/an/a
Exagen Inc. XGN$141 millionn/a-154.9%-18.6%20.8%1.87n/a
LifeMD, Inc. LFMD$113 millionn/an/an/an/a0.00n/a
Sera Prognostics, Inc. SERA$112 millionn/a-63.8%-38,755.2%1.1%0.00n/a
Park Dental Partners, Inc. PARK$94 millionn/an/an/an/a0.37n/a
Biodesix Inc. BDSX$94 millionn/a-312.1%-18.7%31.2%5.76n/a
Airsculpt Technologies, Inc. AIRS$39 millionn/a-8.9%-4.7%-6.3%0.35n/a
5 companies share its SEC industry code (Services-General Medical & Surgical Hospitals, Nec); the rest are the names nearest in size in its wider industry, Healthcare, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on UHS

Dividends$0.80 a share over the four quarters to 30 September 2026, a 0.41% yield
Filings22 in twelve months: 14 current reports (8-K), about 4 results of operations; 4 material agreement; 4 new financial obligation; 3 other events; 3 officer or director change
Planned insider sales3 Form 144 notices in twelve months, $980,442; latest 13 March 2026
Options tapeput/call 0.62 by open interest at the 6 November 2026 close; the straddle prices a 6.1% move to 20 November 2026
13F holders599 funds reported a position for the quarter to 30 June 2026; largest First Eagle Investment Management, LLC
Insider trading4 sales and 0 purchases on Form 4 in twelve months
Congress0 House trades disclosed in six months
Short interest2.6 million shares short, 4.87 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 20266 November 2026EDGAR
10-Q30 June 20267 August 2026EDGAR
10-Q31 March 20267 May 2026EDGAR
10-K31 December 202525 February 2026EDGAR
10-Q30 September 20257 November 2025EDGAR
10-Q30 June 20258 August 2025EDGAR
10-Q31 March 20258 May 2025EDGAR
10-K31 December 202426 February 2025EDGAR
10-Q30 September 20248 November 2024EDGAR
10-Q30 June 20248 August 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.